Predictive Oncology Files 8-K
Ticker: AGPU · Form: 8-K · Filed: Apr 7, 2025 · CIK: 1446159
Sentiment: neutral
Topics: sec-filing, regulation-fd
Related Tickers: PRED
TL;DR
PRED filed an 8-K on 4/7 for an event on 4/3 - Reg FD disclosure.
AI Summary
Predictive Oncology Inc. filed an 8-K on April 7, 2025, reporting an event that occurred on April 3, 2025. The filing is categorized under Regulation FD Disclosure, indicating it contains material information that may be of interest to the public. No specific financial transactions or material events are detailed in the provided text excerpt.
Why It Matters
This filing signals that Predictive Oncology Inc. has disclosed material information to the SEC, which could impact investor understanding of the company's current status.
Risk Assessment
Risk Level: low — The provided text is a standard SEC filing header and does not contain specific operational, financial, or strategic information that would indicate a high-risk event.
Key Players & Entities
- Predictive Oncology Inc. (company) — Registrant
- 001-36790 (company) — SEC File Number
- 33-1007393 (company) — IRS EIN
- April 3, 2025 (date) — Earliest event date
- April 7, 2025 (date) — Filing date
FAQ
What specific event triggered this 8-K filing for Predictive Oncology Inc. on April 3, 2025?
The provided excerpt does not specify the exact event, only that it falls under Regulation FD Disclosure.
What is the significance of the 'Regulation FD Disclosure' category for this filing?
Regulation FD Disclosure means the company is reporting material information that may have been disclosed non-publicly, ensuring fair disclosure to all investors.
When was Predictive Oncology Inc. incorporated or organized?
The company was incorporated in Delaware.
What is the primary business address of Predictive Oncology Inc.?
The business address is 91 43rd Street, Suite 110, Pittsburgh, PA 15201.
Has Predictive Oncology Inc. undergone previous name changes?
Yes, the company was formerly known as Skyline Medical Inc. (name change effective August 7, 2013) and Precision Therapeutics Inc. (name changes effective February 8, 2018, and March 14, 2018).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 7, 2025 regarding Predictive Oncology Inc. (AGPU).